BioSpace News Archive

FDA

AstraZeneca’s Farxiga Picks Up Another FDA Approval

Thanks to a new regulatory win, AstraZeneca’s Farxiga can now be used to reduce the risk of hospitalization for heart failure in type 2 diabetes patients with cardiovascular disease and with certain risk factors.

October 21, 2019
·
2 min read
·
Alex Keown
FDA

Janssen’s Stelara Wins FDA Approval for Ulcerative Colitis

The approval is based on the Phase III UNIFI study that showed that after eight weeks of taking a single intravenous dose of Stelara, patients saw “clinical remission in a significantly greater proportion of UC patients.”

October 21, 2019
·
2 min read
·
Alex Keown
New polysomnography electrode set enables easy at-home assessment of sleep bruxism

An easy-to-use electrode set can assess sleep bruxism severity as well as a conventional polysomnography, a new study from the University of Eastern Finland shows

October 21, 2019
·
4 min read
Business

Promore Pharma engages ABG Sundal Collier as liquidity provider

Promore Pharma AB announced that the company has entered into an agreement with ABG Sundal Collier ASA whereby ABGSC will act as liquidity provider for the Promore Pharma share starting 21 October.

October 21, 2019
·
1 min read
Policy

Vamorolone Designated Promising Innovative Medicine (PIM) for Treatment of Duchenne Muscular Dystrophy by the UK MHRA

Santhera Pharmaceuticals announces that the UK’s Medicines and Healthcare Products Regulatory Agency has informed ReveraGen BioPharma about having designated vamorolone as Promising Innovative Medicine for the treatment of Duchenne muscular dystrophy

October 21, 2019
·
5 min read
Business

Achilles Therapeutics Appoints Beverley Carr as Chief Business Officer

Achilles Therapeutics, a biopharmaceutical company developing personalised cancer immunotherapies, announces it has appointed Beverley Carr as Chief Business Officer, with effect from 4 November 2019.

October 21, 2019
·
2 min read
Business

ISCT forms cell and gene therapy sector-wide coalition to combat the rise of unproven commercial cell banking services

ISCT announces it has formed a global consortium of a wide range of leading professional and education societies to combat the rise in the number of unproven commercial cell banking services.

October 21, 2019
·
3 min read
Sartorius Stedim Biotech Launches New Sartocheck® 5 Plus Filter Tester

Sartorius Stedim Biotech, a leading international supplier for the biopharmaceutical industry, has announced the launch of its new Sartocheck® 5 Plus filter integrity tester.

October 21, 2019
·
4 min read
Business

Verseau Therapeutics Launches with $50 Million to Reprogram Immune Cells to Treat Cancer

Verseau’s lead product targets PSGL-1 (P-selectin glycoprotein ligand-1), which is an adhesion molecule involved in immune cell trafficking in response to tissue injury or inflammation, according to the company.

October 21, 2019
·
3 min read
·
Alex Keown
Business

Generational Priorities: What Baby Boomers, Gen-Xers and Millennials Think Makes an Ideal Employer

When it comes to specific attributes, having the opportunity to do interesting and meaningful work, securing a competitive salary and having access to quality health benefits were the most important. Here are some differences when it comes to generational priorities.

October 21, 2019
·
3 min read
·
Porschia Parker